FDA removes semaglutide from drug shortage list
The FDA has removed semaglutide from its drug shortage list after the agency determined the current supply of the drug can meet present and future demand, Novo Nordisk announced.On Feb. 21, the FDA updated its drug shortage list and listed the shortage of all doses of injectable semaglutide (Ozempic/Wegovy) as being resolved.
The Food and Drug Administration on Friday announced that semaglutide, the active ingredient in weight loss drugs Ozempic and ...
the New Zealander resolved to take action. In late 2022, at the age of 46, Cook joined a clinical trial that set out to ...
ABC News on MSN9d
Weight loss drug semaglutide may reduce alcohol cravings, heavy drinking and smoking, new study findsSemaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit -- it could help ...
Following the resolution of Eli Lilly’s tirzepatide shortage in October, the FDA has officially declared an end to the supply ...
"They’re priced for profits, not patients.” That’s the critique from Hims & Hers Health’s buzzy — and controversial — Super ...
Discover how this diabetes drug is revolutionizing heart health. Learn about its surprising benefits in reducing cardiovascular risks and mortality.
A randomized, placebo-controlled trial validates a side effect frequently observed by doctors and patients. A new study from ...
A small study confirms observations what users have observed: the medications reduce their cravings for alcohol.
A new study suggests that using weight loss drugs such as Ozempic and Wegovy can lead to less alcohol consumption. The study, ...
Adults with type 2 diabetes may have a higher risk for developing nonarteritic anterior ischemic optic neuropathy while using ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback